Scotiabank Just Hiked Cameco Price Target to $175 as the Nuclear Renaissance Accelerates

Cameco (NYSE:CCJ | CCJ Price Prediction) stock just earned a fresh vote of confidence from Bay Street. Scotiabank analyst Orest Wowkodaw raised his CCJ stock price target to $175 from $150, keeping an Outperform rating after a quarterly update he characterized as positive given higher estimates. The takeaway for prudent investors: the Western nuclear renaissance is shifting from thesis to policy-backed build cycle, and Cameco sits at the center of it.

Cameco shares trade at $120 and change, with the stock up 32% year to date (YTD) and 151% over one year. Scotiabank’s new target sits above the consensus average of $150.40.

The Analyst’s Case

Wowkodaw’s bullish stance on Cameco rests on improving fundamentals tied to Western World agendas of decarbonization, energy independence, and power security. Those three priorities now move together, with governments funding nuclear capacity to cut emissions, reduce reliance on adversarial fuel suppliers, and secure baseload power for AI-era data centers.

The supply-demand setup reinforces the call. Uranium production is long-cycle, secondary supplies have thinned, and hyperscaler power purchase agreements (think Microsoft‘s (NASDAQ:MSFT) Three Mile Island restart and Amazon‘s (NASDAQ:AMZN) Talen deal) have moved nuclear from background option to strategic fuel.

Company Snapshot

Cameco is the largest publicly traded pure-play uranium producer in the Western world, with high-grade Canadian assets and a global contract book. Its 49% stake in Westinghouse Electric Company, held jointly with Brookfield, extends its reach into reactor services and new builds.

The company’s Q1 2026 results, released May 5, showed adjusted EPS of $0.47 and profit of $131 million, up from $70 million a year earlier. Cameco also signed a $2.6 billion CAD uranium supply agreement with India spanning 2027-2035, reinforcing multi-year revenue visibility.

Why the Move Matters Now

The “Western World” framing is doing real work for Cameco here. Enrichment and conversion capacity outside Russia and China is now a strategic priority, and 78 GW of nuclear capacity is currently under construction globally against a structural long-term supply deficit.

The valuation looks rich, though. Cameco trades at a P/E ratio of 104x, with a market cap of roughly $52.66 billion. That reflects both scarcity value and high expectations baked in. For a deeper read on how AI power demand is reshaping the energy stack, see this analysis of AI-era uranium beneficiaries.

What It Means for Your Portfolio

For long-term investors, Scotiabank’s price target raise reinforces a thesis already endorsed by 12 buys and 3 holds across major brokerages. Cameco stock offers diversified exposure across mining, fuel services, and reactor technology via Westinghouse.

Yet, uranium markets are notoriously cyclical, and Cameco has run hard already. Bear concerns include execution risk on Westinghouse, project delays in new uranium production, and the possibility that nuclear new-build timelines slip past current schedules.

For Cameco investors, the prudent path is moderate position sizing and patience. The structural drivers behind the analyst upgrade look durable, but volatility around uranium pricing and contracting cycles remains a real risk that prudent investors should respect.